Humoral immune responses of cancer patie
✍
Elke Jäger; Elisabeth Stockert; Zacharias Zidianakis; Yao-Tseng Chen; Julia Karb
📂
Article
📅
1999
🏛
John Wiley and Sons
🌐
French
⚖ 165 KB
👁 2 views
Humoral immune responses against the ''Cancer-Testis'' (CT) antigen NY-ESO-1 are frequently observed in patients with NY-ESO-1 expressing tumors. This is in contrast to other known tumor antigens (TA) defined by antibody or cytotoxic T cell (CTL) reactivity, i.e., MAGE-1, MAGE-3, SSX2, Melan A, and